214
Participants
Start Date
March 1, 2016
Primary Completion Date
March 1, 2024
Study Completion Date
March 1, 2026
Etoposide
etoposide 100mg/m2 ivgtt started at the first day of cycle, two weeks a cycle
actinomycin D
actinomycin D 500ug ivgtt, started at the first day of cycle, two weeks a cycle
methotrexate
methotrexate 100mg/m2, 200mg/m2, ivgtt, tetrahydrofolic acid (FA) 15mg q12h\*4(24h after methotrexate injection),started at the first day of cycle, two weeks a cycle
vincristine
vincristine 1mg/m2 started at the 8th day of cycle, two weeks a cycle
cyclophosphamide
cyclophosphamide 600mg/m2, started at the 8th day of cycle, two weeks a cycle
Paclitaxel
paclitaxel 135mg/m2, started at the first day of cycle, two weeks a cycle
Cisplatin
cisplatin 50mg/m2, started at the first day of cycle, two weeks a cycle
Carboplatin
carboplatin area under curve (AUC)=4-5, started at the first day of cycle, two weeks a cycle,as a substitute drug for cisplatin
RECRUITING
Weiguo Lv, Hangzhou
Shandong University
OTHER
Huazhong University of Science and Technology
OTHER
First Affiliated Hospital of Zhongshan Medical University
OTHER
Weiguo Lv
OTHER